Addiction treatment services and co-occurring disorders: The ASAM-PPC-2R taxonomy of program dual diagnosis capability

Journal of Addictive Diseases

Volumn 26, Issue 3, 2007, Pages 27-37

  McGovern, Mark P ^a   Xie, Haiyi ^a   Acquilano, Stephanie ^a   Segal, Samuel R ^b   Siembab, Lauren ^c   Drake, Robert E ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b Chief Medical Officer   (United States)

^c Health Care Systems   (United States)

Author keywords

Addiction Only Services (AOS); Addiction treatment programs; Dual Diagnosis Capable (DDC); Dual Diagnosis Enhanced (DDE); Psychiatric disorders

Indexed keywords

ADULT; AMERICAN SOCIETY OF ADDICTION MEDICINE PATIENT PLACEMENT CRITERIA; ARTICLE; CLINICAL PRACTICE; COMORBIDITY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DRUG DEPENDENCE TREATMENT; HEALTH CARE SYSTEM; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; MENTAL DISEASE; SUBSTANCE ABUSE; TAXONOMY;

CROSS-SECTIONAL STUDIES; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HEALTH PERSONNEL; HUMANS; MALE; MENTAL DISORDERS; MENTAL HEALTH SERVICES; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 34548400352     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1300/J069v26n03_04     Document Type: Article

References (24)

1. Substance Abuse and Mental Health Services Administration. Report to Congress on the prevention and treatment of co-occurring substance abuse disorders and mental disorders. Rockville MD: U.S. DHHS, SAMHSA; 2002.
2. Brunette MF, Mueser KT, Drake RE. A review of research on residential programs for people with severe mental illness and co-occurring substance use disorders. Drug Alcohol Rev. Dec 2004; 23(4):471-481.
3. Brunette MF, Noordsy DL, Buckley P, Green AI. Pharmacologic treatments for co-occurring substance use disorders in patients with schizophrenia: A research review. J Dual Diagn. 2005; 1:41-55.
4. Drake RE, Mueser KT, Brunette MF, McHugo GJ. A review of treatments for people with severe mental illnesses and co-occurring substance use disorders. Psychiatr Rehabil J. Spring 2004; 27(4):360-374.
5. Mueser KT, Drake RE, Sigmon SC, Brunette MF. Psychosocial interventions for adults with severe mental illness and co-occurring substance use disorders: A review of specific interventions. J Dual Diagn. 2005; 1:57-85.
6. Xie H, McHugo GJ, Fox MB, Drake RE. Substance abuse relapse in a ten-year prospective follow-up of clients with mental and substance use disorders. Psychiatr Serv. Oct 2005; 56(10):1282-1287.
7. Center for Substance Abuse Treatment. Substance abuse treatment for persons with co-occurring disorders. Treatment Improvement Protocol (TIP) Series 42/DHHS Publication no. (SMA) 05-3992. Rockville MD: Substance Abuse and Mental Health Services Administration; 2005.
8. Hunter SB, Watkins KE, Wenzel S, Gilmore J, Sheehe J, Griffin B. Training substance abuse treatment staff to care for co-occurring disorders. J Subst Abuse Treat. Apr 2005; 28(3):239-245.
9. Watkins KE, Hunter SB, Burnam MA, Pincus HA, Nicholson G. Review of treatment recommendations for persons with a co-occurring affective or anxiety and substance use disorder. Psychiatr Serv. Aug 2005; 56(8):913-926.
10. Brady KT, Dansky BS, Back SE, Foa EB, Carroll KM. Exposure therapy in the treatment of PTSD among cocaine-dependent individuals: Preliminary findings. J Subst Abuse Treat. Jul 2001; 21(1):47-54.
11. Randall CL, Thomas S, Thevos AK. Concurrent alcoholism and social anxiety disorder: A first step toward developing effective treatments. Alcohol Clin Exp Res. Feb 2001; 25(2):210-220.
12. McRae AL, Sonne SC, Brady KT, Durkalski V, Palesch Y. A randomized, placebo-controlled trial of buspirone for the treatment of anxiety in opioid-dependent individuals. Am J Addict. Jan-Feb 2004; 13(1):53-63.
13. Cacciola JS, Alterman AI, McKay JR, Rutherford MJ. Psychiatric comorbidity in patients with substance use disorders: Do not forget Axis II disorders. Psychiatr Ann. 2001; 31:321-331.
14. Pincus HA, Burnam MA, Magnabosco K, Dembosky JW, Greenberg M. State activities to improve services and systems of care for individuals with co-occurring mental and addictive disorders. Santa Barbara CA: Rand; 2005.
15. Mee-Lee D, Shulman GD, Fishman M, Gastfriend DR, Griffith JH. eds. ASAM patient placement criteria for the treatment of substance-related disorders. Second Edition-Revised. (ASAM-PPC-2R). Chevy Chase MD: American Society of Addiction Medicine, Inc.; 2001.
16. Gastfriend DR, Mee-Lee D. The ASAM patient placement criteria: Context, concepts and continuing development. J Addict Dis. 2003; 22 Suppl 1:1-8.
17. Minkoff K, Zweben J, Rosenthal R, Ries R. Development of service intensity criteria and program categories for individuals with co-occurring disorders. J Addict Dis. 2003; 22 Suppl 1:113-129.
18. Ball S, Bachrach K, DeCarlo J, et al. Characteristics, beliefs, and practices of community clinicians trained to provide manual-guided therapy for substance abusers. J Subst Abuse Treat. Dec 2002; 23(4):309-318.
19. Foreman RF, Bovasso G, Woody G, et al. Staff beliefs about drug abuse clinical trials. J Subst Abuse Treat. 2002; 24:183-196.
20. Gallon SL, Gabriel RM, Knudsen JR. The toughest job you'll ever love: A Pacific Northwest Treatment Workforce Survey. J Subst Abuse Treat. Apr 2003;24(3):183-196.
21. McGovern MP, Fox TS, Xie H, Drake RE. A survey of clinical practices and readiness to adopt evidence-based practices: Dissemination research in an addiction treatment system. J Subst Abuse Treat. Jun 2004; 26(4):305-312.
22. Carroll KM, Nich C, Sifry RL, et al. A general system for evaluating therapist adherence and competence in psychotherapy research in the addictions. Drug Alcohol Depend. Jan 2000; 57(3):225-238.
23. Mueser KT, Noordsy DL, Drake RE, Fox L. Integrated treatment for dual disorders. New York: Guilford; 2003.
24. Drake RE, Goldman HH, Leff HS, et al. Implementing evidence-based practices in routine mental health service settings. Psychiatr Serv. Feb 2001; 52(2):179-182.